v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,498 $ 4,828
Accounts receivable 4,983 5,032
Other current assets 1,841 2,294
Total current assets 10,322 12,154
Property and equipment, net 790 480
Other intangible assets, net 861
Operating lease right of use assets 1,864 2,439
Other long-term assets 45 45
Total assets 13,021 15,979
Current liabilities:    
Accounts payable 1,544 1,050
Accrued salary and bonus 1,969 1,456
Other accrued expenses 8,201 8,419
Note payable at fair value, current 5,100
Line of credit - current 2,500
Current liabilities of discontinued operations 660 858
Total current liabilities 17,474 14,283
Contingent consideration 518
Operating lease liabilities, net of current portion 1,472 1,848
Note payable at fair value 4,243 11,165
Other long-term liabilities 4,968 4,701
Total liabilities 28,157 32,515
Commitments and contingencies (Note 11)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,447,489 and 4,367,830 shares issued, respectively; 4,351,445 and 4,296,710 shares outstanding, respectively 405 405
Additional paid-in capital 188,146 187,516
Accumulated deficit (248,215) (249,017)
Treasury stock, at cost (96,044 and 71,120 shares, respectively) (2,008) (1,976)
Total stockholders’ deficit (61,672) (63,072)
Total liabilities and stockholders’ deficit (33,515) (30,557)
Total liabilities, preferred stock and stockholders’ deficit $ 13,021 $ 15,979

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL